Medicus Pharma Ltd. Common Stock (MDCX) — Cash Flow-to-Debt Ratio
Medicus Pharma Ltd. Common Stock (MDCX) has a Cash Flow-to-Debt Ratio of -1.09x as of March 2026, meaning its operating cash flow of $-6.51 Million could theoretically repay -1% of its total liabilities ($6.00 Million) in one year. See MDCX equity financing ratio to measure how much of total assets are equity-financed.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Medicus Pharma Ltd. Common Stock Cash Flow-to-Debt Ratio (2010–2025)
Historical debt coverage capacity for Medicus Pharma Ltd. Common Stock across 9 annual periods. See MDCX FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Annual Cash Flow-to-Debt Ratio for Medicus Pharma Ltd. Common Stock (2010–2025)
Year-by-year debt coverage analysis for Medicus Pharma Ltd. Common Stock. For the full cash flow conversion analysis, see Medicus Pharma Ltd. Common Stock cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.27x | $-22.78 Million | $10.02 Million | ▲ +44.3% |
| 2024 | -4.08x | $-10.25 Million | $2.51 Million | ▲ +23.3% |
| 2023 | -5.32x | $-4.16 Million | $781.61K | ▼ -6181.2% |
| 2022 | -0.08x | $-1.06 Million | $12.48 Million | ▲ +38.1% |
| 2021 | -0.14x | $-1.45 Million | $10.58 Million | ▲ +78.6% |
| 2017 | -0.64x | $-65.99K | $103.23K | ▼ -89.4% |
| 2016 | -0.34x | $-3.10K | $9.18K | ▲ +62.8% |
| 2015 | -0.91x | $-3.10K | $3.42K | ▼ -276.9% |
| 2010 | -0.24x | $-1.20 Million | $5.00 Million | — |